Felice Verduyn - Van Weegen
InvestorPartner at EQT Life Sciences
Amsterdam, Netherlands
Writes $11M β $65M checks Β· typically $25M
FoundedEvommune
Experience
- EQT GroupPartnercurrent2022 β presentAmsterdam, North Holland, Netherlands
- Agomab TherapeuticsMember Board of Directorscurrent2023 β presentGent, Vlaanderen, BelgiΓ«
- EvommuneMember Board Of Directorscurrent2021 β presentVerenigde Staten
- Noema PharmaMember Board of Directorscurrent2024 β present
- Vico TherapeuticsMember of the Supervisory Boardcurrent2019 β presentLeiden, Provincie Zuid-Holland, Nederland
- Egle TherapeuticsMember Board Of Directorscurrent2021 β present
- LSPPartnercurrent2021 β present
- LSPInvestment Manager2015 β 2021Amsterdam Area
- EQT FoundationChairman of Grant Committeecurrent2025 β present
- De ZorgambassadeChairman of the supervisory board2019 β 2026
- Amolyt PharmaMember Board Of Directors2019 β 2024Lyon Area, France
- Pharvaris B.V.Board Observer2016 β 2021
- ONWARDBoard Observer2015 β 2018
- McKinsey & CompanyFellow2012 β 2014
- Harvard Medical SchoolGenetic research fellow2011Boston
- Vrije Universiteit AmsterdamGenetic and Twin Research2009 β 2011
- Dutch Twin Registry - Vrije UniversiteitGenetic and Twin Research2010
Education
- Columbia Business SchoolMaster of Business Administration (MBA)2014 β 2015
- Vrije Universiteit Amsterdam (VU Amsterdam)MsC, Neurosciences2005 β 2011
- Erasmus University RotterdamMsC, Neurosciences2010
- Vrije Universiteit Amsterdam (VU Amsterdam)Bachelor's degree, Biological Psychology2005 β 2008
Skills & more
Dutch3Strategy8Management4Statistics7Research6Neuroscience3SPSS3Business Strategy9Management Consulting8Data Analysis2Due Diligence3Valuation4
+3 more
Mergers & AcquisitionsCorporate FinanceEntrepreneurshipFrom Felice's professional profile.
Same school
Also attended Columbia Business School580
Aryo TehranianManaging Director at Mayfair Equity PartnersYibo NianInvestment Director at Intel CapitalKesha CashFounder & General Partner at Impact America FundMahati SridharPartner, Rise of the Rest at RevolutionGiuseppe IademarcoHead of Global Partnership at P101 VenturesWendy XiaoPartner at Northzone
+ 574 more
Also attended Vrije Universiteit Amsterdam (VU Amsterdam)126
Brendan Bulik-SullivanInvestor at GV (Google Ventures)Kyang YungInvestor at DaphniJohann FriederichAssociate at Notion CapitalTies KlinkhamerJunior Associate at Keen Venture PartnersLidwi van OsProgram & Office Support Officer at NoaberMehmet AkalinExperts | Venture Partner at 212
+ 120 more
Also attended Erasmus University Rotterdam151
Alessandro TavecchioPartner at P101 VenturesDick SietsesInvestment Partner Health at Capricorn Venture PartnersKonradInvestment Team at Hummingbird VenturesProf. Dr. Elbert DijkgraafBestuurslid at NoaberJohanneke van de Scheur-BaanBestuurslid at NoaberMaarten FischerHead of Programs at Noaber
+ 145 more
Shared employers
Also worked at Vico Therapeutics3
Also worked at LSP11
Anna BellmuntSenior Associate at Asabys PartnersRuben OsnabruggePartner & Chief Medical Officer at 415 CapitalJoachim RothePartner at EQT Life SciencesFouad AzzamPartner at EQT Life SciencesAnne PortwichPartner at EQT Life SciencesHarm de VriesPartner and Co-Founder at Innovation Industries
+ 5 more
Also worked at De Zorgambassade1
Also worked at Pharvaris B.V.1
Deals Β· 1
EvommuneBoard seat
via EQT Life Sciences Β· filed Jan 2025 Β· $115.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at EQT Life Sciences
Alexandra Edlund
Chief People Officer at EQT Life Sciences
Anne Portwich
Partner at EQT Life Sciences
Arno de Wilde
Investor at EQT Life Sciences
Bert Janssens
Partner, Co-Head of Private Capital at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Christina Drews
Chief Operating Officer at EQT Life Sciences
Christoph Broja
Partner at EQT Life Sciences
Cillian King
Managing Director at EQT Life Sciences
Network5
Amy Schulman
Managing Partner at Polaris Partners
Antoine Papiernik Papiernik
Chairman and Managing Partner at Sofinnova Partners
Ishaan Tewarie
Vice President at EQT Life Sciences
Nanna Luneborg
General Partner at Forbion
Rudy Dekeyser
Partner, Head of Health Economic Funds at EQT Life Sciences
Investors connected to Felice in public investor directories β a warm-intro map.

































